Its mechanism of action is not yet fully elucidated, however some studies on cancer describe PP as a CK1α agonist that promotes β-Catenin degradation [24, 42], a mechanism also observed in uveal melanoma [43]. Here, CSNK1A1 is linked to uveal melanoma.